Intratect (Human Normal Immunoglobulin)

Intratect is used in immunoglobulin therapy to replace deficient antibodies in various immunodeficiency conditions.

• Primary immunodeficiency diseases: restores IgG levels to reduce infection frequency and severity.
• Secondary immunodeficiency conditions: provides passive immunity for patients with acquired antibody deficiencies, such as those undergoing chemotherapy.
• Antibody deficiency syndromes: supplies pooled IgG to support immune function and prevent opportunistic infections.

• Human Normal Immunoglobulin supplies a broad spectrum of pooled IgG antibodies derived from healthy donors. After intravenous infusion, the IgG distributes throughout the vascular and extravascular compartments, where it binds to pathogens, toxins, and immune complexes, neutralizing them and facilitating clearance via Fc‑mediated mechanisms. This passive immunity also modulates immune cell activity, helping to regulate inflammatory responses and support deficient humoral immunity.

Intratect may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects

• Headache: mild to moderate intensity, often transient.
• Fever or chills: low‑grade temperature elevation after infusion.
• Nausea: occasional gastrointestinal discomfort.
• Fatigue: general feeling of tiredness.
• Injection site reactions: erythema, swelling, or discomfort at the infusion site.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical intervention.
• Thromboembolic events: rare clot formation in veins or arteries.
• Renal impairment: acute kidney injury in susceptible individuals.
• Hemolysis: destruction of red blood cells leading to anemia.
• Aseptic meningitis: inflammation of meninges without infection.

When using Intratect, several precautions should be observed to ensure patient safety and product integrity.

• Patient assessment: evaluate immune status and infection history before initiating therapy.
• Infusion rate: administer slowly and monitor vital signs to reduce risk of reactions.
• Pre‑medication: consider antihistamines or antipyretics to mitigate infusion‑related symptoms.
• Renal function: assess kidney function, especially in patients with pre‑existing impairment.
• Volume overload: monitor fluid balance in patients with cardiac or pulmonary disease.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intratect can interact with other medicines, influencing safety or efficacy.

Major Interactions (Avoid)

• Live vaccines: concurrent administration may reduce vaccine effectiveness or increase adverse events.
• High‑dose immunosuppressants: may diminish the therapeutic benefit of administered immunoglobulin.

Moderate Interactions (Monitor Closely)

• Anticoagulants: immunoglobulin can affect coagulation parameters; monitor INR or aPTT.
• Diuretics: increased risk of renal strain; observe fluid status.
• ACE inhibitors: potential for additive blood pressure effects; check blood pressure regularly.